Functional CD3+CD8+PD1- T Cell Accumulation and PD-L1 Expression Increases During Tumor Invasion in DCIS of the Breast

被引:11
作者
Lv, Shuzhen [1 ,2 ]
Wang, Shuo [1 ]
Qiao, Guoliang [1 ]
Wang, Xiaoli [1 ]
Zhou, Xinna [1 ]
Yan, Fengcai [3 ]
Li, Yanping [2 ]
Wang, Suya [1 ]
Morse, Michael A. [4 ,5 ]
Hobeika, Amy [5 ]
Ren, Jun [1 ,5 ]
Lyerly, Herbert Kim [5 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Med Oncol, Canc Ctr,Beijing Key Lab Therapeut Canc Vaccines, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Shijitan Hosp, Canc Ctr, Dept Breast Surg Oncol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Shijitan Hosp, Dept Pathol, Beijing, Peoples R China
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
关键词
Breast cancer; Immune phenotype; Opal technique; PD1 immune microenvironment; T cells expression; TERTIARY LYMPHOID STRUCTURES; INFILTRATING LYMPHOCYTES; MICROENVIRONMENT; ASSOCIATION; RELEVANCE; PATHWAYS; PATIENT; CANCER; TILS;
D O I
10.1016/j.clbc.2019.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We explored quantitative T-cell distribution among samples of 49 patients with ductal carcinoma in situ vs. those with minimal infiltration lesions to find the functional alterations. CD3(+)DC8(+) programmed death 1-negative T cell and programmed death ligand 1-positive expression increased as disease progressed. Background: The changes in T cell subsets and programmed death ligand 1 (PD-L1) expression during the transition from ductal carcinoma in situ (DCIS) to early invasive breast cancer had not been well studied. Patients and Methods: A total of 85 DCIS patients were classified into 49 DCIS (clinical stage: Tis, noninvasive) and 36 with a minimally infiltrating lesion (MIL; < 5 mm; clinical stage: T1a). We explored the quantitative alterations of T-cell markers and PD-L1 in these groups using the Opal multi-immunohistochemistry technique. Results: We observed increased infiltration of CD3-positive (CD3(+))CD8(+) programmed death 1 (PD1)-negative T cells and higher PD-L1 expression in DCIS with MIL. Elevated PD1 expression correlated with PD-L1 expression in MIL and DCIS. Conclusion: We conclude that during the transition from DCIS to an invasive lesion, the host cytolytic T cells begin interacting with the tumor and destroy the tumor tissue, leading to an adaptive upregulation of PD-L1 and tumor protection against immune destruction. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:E617 / E623
页数:7
相关论文
共 27 条
[1]   Emotions and Emotion Regulation in Breast Cancer Survivorship [J].
Conley, Claire C. ;
Bishop, Brenden T. ;
Andersen, Barbara L. .
HEALTHCARE, 2016, 4 (03)
[2]   Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition [J].
Del Alcazar, Carlos R. Gil ;
Huh, Sung Jin ;
Ekram, Muhammad B. ;
Trinh, Anne ;
Liu, Lin L. ;
Beca, Francisco ;
Zi, Xiaoyuan ;
Kwak, Minsuk ;
Bergholtz, Helga ;
Su, Ying ;
Ding, Lina ;
Russnes, Hege G. ;
Richardson, Andrea L. ;
Babski, Kirsten ;
Kim, Elizabeth Min Hui ;
McDonnell, Charles H., III ;
Wagner, Jon ;
Rowberry, Ron ;
Freeman, Gordon J. ;
Dillon, Deborah ;
Sorlie, Therese ;
Coussens, Lisa M. ;
Garber, Judy E. ;
Fan, Rong ;
Bobolis, Kristie ;
Allred, D. Craig ;
Jeong, Joon ;
Park, So Yeon ;
Michor, Franziska ;
Polyak, Kornelia .
CANCER DISCOVERY, 2017, 7 (10) :1098-1115
[3]   Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial [J].
Donker, Mila ;
Litiere, Saskia ;
Werutsky, Gustavo ;
Julien, Jean-Pierre ;
Fentiman, Ian S. ;
Agresti, Roberto ;
Rouanet, Philippe ;
de lara, Christine Tunon ;
Bartelink, Harry ;
Duez, Nicole ;
Rutgers, Emiel J. T. ;
Bijker, Nina .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4054-4059
[4]   Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells [J].
Eppihimer, MJ ;
Gunn, J ;
Freeman, GJ ;
Greenfield, EA ;
Chernova, T ;
Erickson, J ;
Leonard, JP .
MICROCIRCULATION, 2002, 9 (02) :133-145
[5]   Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression [J].
Garcia-Diaz, Angel ;
Shin, Daniel Sanghoon ;
Moreno, Blanca Homet ;
Saco, Justin ;
Escuin-Ordinas, Helena ;
Rodriguez, Gabriel Abril ;
Zaretsky, Jesse M. ;
Sun, Lu ;
Hugo, Willy ;
Wang, Xiaoyan ;
Parisi, Giulia ;
Saus, Cristina Puig ;
Torrejon, Davis Y. ;
Graeber, Thomas G. ;
Comin-Anduix, Begonya ;
Hu-Lieskovan, Siwen ;
Damoiseaux, Robert ;
Lo, Roger S. ;
Ribas, Antoni .
CELL REPORTS, 2017, 19 (06) :1189-1201
[6]   FOXP3+ Tregs and B7-HI+/PD-I+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients:: Implication for immunotherapy [J].
Ghebeh, Hazem ;
Barhoush, Eman ;
Tulbah, Asma ;
Elkum, Naser ;
Al-Tweigeri, Taher ;
Dermime, Said .
BMC CANCER, 2008, 8 (1)
[7]  
Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]
[8]   Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features [J].
Hendry, Shona ;
Pang, Jia-Min B. ;
Byrne, David J. ;
Lakhani, Sunil R. ;
Cummings, Margaret C. ;
Campbell, Ian G. ;
Mann, G. Bruce ;
Gorringe, Kylie L. ;
Fox, Stephen B. .
CLINICAL CANCER RESEARCH, 2017, 23 (17) :5210-5217
[9]   A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA [J].
Jang, Bum-Sup ;
Kim, In Ah .
RADIOTHERAPY AND ONCOLOGY, 2018, 128 (02) :245-253
[10]   PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity [J].
Juneja, Vikram R. ;
McGuire, Kathleen A. ;
Manguso, Robert T. ;
LaFleur, Martin W. ;
Collins, Natalie ;
Haining, W. Nicholas ;
Freeman, Gordon J. ;
Sharpe, Arlene H. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (04) :895-904